| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
familial cortical myoclonic tremor with epilepsy 2 | 0.743 | 0.231 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2013 | |||||||||
|
sex determining region Y | 0.456 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2007 | |||||||||
|
telomerase RNA component | 0.471 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2016 | |||||||||
|
TERT 5' regulatory region | 0.464 | 0.731 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2017 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 2002 | |||||||||
|
H3 histone pseudogene 40 | 0.506 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2012 | |||||||||
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation) | 0.641 | 0.462 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2008 | |||||||||
|
taste 2 receptor member 62 pseudogene | 0.729 | 0.192 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2017 | |||||||||
|
s-rRNA | 0.626 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2014 | |||||||||
|
UDP glucuronosyltransferase family 1 member A complex locus | 0.540 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1992 | 1997 | |||||||||
|
Wilms tumor-4 | 0.821 | 0.154 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1998 | 2004 | |||||||||
|
RNA, 28S ribosomal N5 | 0.705 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | |||||||||
|
MIA-RAB4B readthrough (NMD candidate) | 0.821 | 0.385 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | |||||||||
|
H19/IGF2 imprinting control region | 0.631 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
competing endogenous lncRNA 3 for miR-645 | 0.531 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
ZPA regulatory sequence | 0.722 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
disrupted in renal carcinoma 1 | 0.861 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | |||||||||
|
cutaneous malignant melanoma/dysplastic nevus | 0.670 | 0.385 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 |